FilingFirehose · free AI preview
Duality Biotherapeutics Inc/ADR
DUTBF · AI-generated SEC analysis preview · refreshes when data changes
Duality Biotherapeutics Inc/ADR (DUTBF) has recorded zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in the near term. However, a limited observation window carries inherent blind spots—low signal in recent months does not preclude material risks in the prior year. The full $49 Report extends analysis to 12 months of SEC filings, assigns a dilution risk score based on equity raise patterns, contextualizes any financing activity, and surfaces early AI-flagged risk signals that routine screening may miss. The full $49 Report adds quantified dilution exposure, 12-month filing history, and AI-detected anomalies across capital structure and governance.
Want the full 5-section $49 Report on DUTBF?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.